Novartis Pharma AG

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Related People
Fund Service Providers
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Novartis Pharma AG
CIK #0001030617
EDGAR Form CIK 2011 - 2026
3 [0001030617]
4 [0001030617]
SC 13D [0001030617]
SC 13G [0001030617]
Form 13D/13G Filer Form 13D/13G Subject Filed
Novartis Pharma AG Erasca Inc [2022-12-19]
Novartis Pharma AG Precision Biosciences Inc [2022-06-27]
Novartis Pharma AG Somalogic Inc [2021-10-08]
Novartis Pharma AG Poseida Therapeutics Inc [2021-02-12]
Novartis Pharma AG Cellular Biomedicine Group Inc [2020-08-14]
Novartis Pharma AG Gamida Cell Ltd [2018-11-08]
Novartis Pharma AG Cellular Biomedicine Group Inc [2018-09-28]
Novartis Pharma AG Akcea Therapeutics Inc [2017-07-27]
Novartis Pharma AG BioLineRx Ltd [2014-12-22]
Form 3/4/5 Subject 2011 - 2026
Novartis Pharma AG
Novartis AG
Precision Biosciences Inc
Cellular Biomedicine Group, Inc.
Poseida Therapeutics, Inc.
Idenix Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc
Terms | Privacy | Providers | Guide
tony@aum13f.com